Insulet
PODD
$342.86
Share price
0.51%
Change (1 day)
53.43%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Earnings for Insulet (PODD)
Earnings in 2024 (TTM): S$0.45 Billion
According to Insulet's latest financial reports the company's current earnings are S$2.07 Billion. , an increase over its 2023 earnings that were of S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Insulet from 2006 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | S$0.45 B | 36.72% |
| 2023 | S$0.32 B | 481.9% |
| 2022 | S$56.68 M | -45.24% |
| 2021 | S$0.10 B | 43.35% |
| 2020 | S$72.19 M | 18.51% |
| 2019 | S$60.92 M | 41.16% |
| 2018 | S$43.16 M | -711.95% |
| 2017 | -S$7.06 Million | -56.85% |
| 2016 | -S$16.35 Million | -79.31% |
| 2015 | -S$79.02 Million | 63.85% |
| 2014 | -S$48.23 Million | 31.04% |
| 2013 | -S$36.81 Million | -21.96% |
| 2012 | -S$47.17 Million | |
| 2010 | -S$44.98 Million | -42.38% |
| 2009 | -S$78.07 Million | -33.56% |
| 2008 | -S$0.12 Billion | 65.93% |
| 2007 | -S$70.81 Million | 209.75% |
| 2006 | -S$22.87 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$53.29 M | -88.18% | 🇺🇸 USA |
 | -S$0.13 Billion | -127.25% | 🇺🇸 USA |
 | S$0.95 B | 112.31% | 🇺🇸 USA |
 | S$22.93 B | 4,986.61% | 🇺🇸 USA |
 | S$9.22 B | 1,945.20% | 🇺🇸 USA |
 | S$7.86 B | 1,643.66% | 🇮🇪 Ireland |
 | S$16.67 B | 3,597.99% | 🇺🇸 USA |